Evidence map›Paper›PMID 39624225›Full record

ArticleToxicology reports2024

An assessment of the prevalence of Aflatoxin M1 level in milk and milk powder based on high performance liquid chromatography and dietary risk assessment.

Yaser Almasoud, Manar Alwelaie, Zeyad Aldosari, Sarah Alotaibi, Abdullah Alsayari, Ghada Alzyadi, Mohammed Almutairi, Sulaiman Alajel, Abdullah Al Tamim, Hibah Alharbi

Abstract read
In one paragraph

Article in Toxicology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yaser AlmasoudSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Manar AlwelaieSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Zeyad AldosariSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Sarah AlotaibiSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Abdullah AlsayariSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Ghada AlzyadiSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Mohammed AlmutairiSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Sulaiman AlajelSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Abdullah Al TamimSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.
Hibah AlharbiSaudi Food and Drug Authority, Riyadh 0112038222, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Milk is susceptible to Aflatoxin M1 (AFM1) contamination, mainly through consumption of contaminated animal's feed. The natural occurrence of aflatoxin M1 (AFB1) has been surveyed in samples of milk and milk powder. Samples collected from different regions of Saudi Arabia during the period from 2013 to 2021 were subjected to high-performance liquid chromatography analysis, and (AFB1) was quantified with detection limits of 0.5 µg/kg. The Saudi Food and Drug Authority has taken strong actions to limit AFM1 contamination, increase aflatoxin control, and modify the regulations. A study analyzed 363 randomly collected milk samples (168 milk, 195 milk powder) from Saudi Arabia using LC-MS/MS. Out of the 363 samples, 20 were positive for AFM1, with 343 were within the limits. One out of the 168 milk samples and 19 out of the 195 milk powder samples exceeded the limits, with seven originating from Saudi Arabia. The highest AFM1 concentration (3.97 µg/kg) was found in the Saudi samples. Saudi Arabia's mycotoxin regulations significantly reduced AFM1 contamination in milk, which is not considered a serious health hazard.

Indexed as

AflatoxinsHealthLC-MS/MSM1MilkRisk

Identifiers

PMID39624225
PMCPMC11609700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.